missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18491398

BMPR-IB/ALK-6 Antibody (MM0055-3E12), DyLight 594, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-12031DL594

Product Code. 18491398

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
 View alternative products »

This item is not returnable. View return policy

Description

Description

BMPR-IB/ALK-6 Monoclonal antibody specifically detects BMPR-IB/ALK-6 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

BMPR-IB/ALK-6
Monoclonal
DyLight 594
activin receptor-like kinase 6, ALK-6, ALK6CDw293, BMP type-1B receptor, BMPR-1B, bone morphogenetic protein receptor type-1B, bone morphogenetic protein receptor, type IB, CDw293 antigen, EC 2.7.11, EC 2.7.11.30, serine/threonine receptor kinase
Human recombinant BMPR-IB/ALK-6 (extracellular domain)
0.1 mL
Mesenchymal Stem Cell Markers, Protein Kinase, Stem Cell Markers
658
Store at 4°C in the dark.
IgG2
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin)
MM0055-3E12
50mM Sodium Borate
Mouse
Protein G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.